Vascular function and risk factors in children with epilepsy: Associations with sodium valproate and carbamazepine

Epilepsy Research

Volumn 108, Issue 6, 2014, Pages 1087-1094

  Keenan, Ngaire ^a   Sadlier, Lynette G ^a   Wiltshire, Esko ^a  

^a UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

Author keywords

Anti epileptic drug; Child; Epilepsy; Vascular function; Vitamin

Indexed keywords

ACETAZOLAMIDE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CARBAMAZEPINE; CHOLESTEROL; CLOBAZAM; CYANOCOBALAMIN; ETHOSUXIMIDE; ETIRACETAM; FOLIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LAMOTRIGINE; LOW DENSITY LIPOPROTEIN; PYRIDOXAL 5 PHOSPHATE; TOPIRAMATE; TRIACYLGLYCEROL; VALPROIC ACID; ANTICONVULSIVE AGENT; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATASE; PYRIDOXAL-5-PHOSPHATASE;

ADOLESCENT; AMINO ACID BLOOD LEVEL; AORTA; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BIOCHEMISTRY; BLOOD VESSEL PARAMETERS; BRACHIAL ARTERY; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; EPILEPSY; FEMALE; FLOW MEDIATED DILATION; FOLIC ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; ECHOGRAPHY; PATHOPHYSIOLOGY; RISK FACTOR;

ADOLESCENT; ANTICONVULSANTS; AORTA; BLOOD GLUCOSE; BRACHIAL ARTERY; CARBAMAZEPINE; CAROTID ARTERIES; CHOLESTEROL; CHOLESTEROL, HDL; EPILEPSY; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; PHOSPHORIC MONOESTER HYDROLASES; RISK FACTORS; VALPROIC ACID; VITAMIN B 12;

EID: 84902270071     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2014.04.006     Document Type: Article

References (45)

1. Apeland T., Mansoor M. Fasting and post-methionine loading concentrations of homocysteine, vitamin B2, and vitamin B6 in patients on antiepileptic drugs. Clin. Chem. 2003, 49:1005-1008.
2. Apeland T., Mansoor M.A., Pentieva K., McNulty H., Seljeflot I., Strandjord R.E. The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs. Epilepsy Res. 2002, 51:237-247.
3. Attilakos A., Papakonstantinou E., Schulpis K., Voudris K., Katsarou E., Mastroyianni S., Garoufi A. Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy. Epilepsy Res. 2006, 71:229-232.
4. Aydin K., Serdaroglu A., Okuyaz C., Bideci A., Gucuyener K. Serum insulin, leptin, and neuropeptide Y levels in epileptic children treated with valproate. J. Child Neurol. 2005, 20:848-851.
5. Belcastro V., Gorgone G., Italiano D., Oteri G., Caccamo D., Pisani L.R., Striano S., Ientile R., Pisani F. Antiepileptic drugs and MTHFR polymorphisms influence hyper-homocystinemia recurrence in epileptic patients. Epilepsia 2007, 48:1990-1994.
6. Belcastro V., Striano P., Gorgone G., Costa C., Ciampa C., Caccamo D., Pisani L.R., Oteri G., Marciani M.G., Aguglia U., Striano S., Ientile R., Calabresi P., Pisani F. Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. Epilepsia 2010, 51:274-279.
7. Belcastro V., Striano P. Antiepileptic drugs, hyperhomocystinemia and B-vitamins supplementation in patients with epilepsy. Epilepsy Res. 2012, 102:1-7.
8. Belcastro V., D'Egidio C., Striano P., Verrotti A. Metabolic and endocrine effects of valproic acid chronic treatment. Epilepsy Res. 2013, 107:1-8.
9. Berenson G., Srinivasan S. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N. Engl. J. Med. 1998, 338:1650-1656.
10. Caccamo D., Condello S., Gorgone G., Crisafulli G., Belcastro V., Gennaro S., Striano P., Pisani F., Ientile R. Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocystinemia. Neuromol. Med. 2004, 6:117-126.
11. Celermajer D., Sorensen K., Gooch V. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992, 340:1111-1115.
12. Chuang Y.-C., Chuang H.-Y., Lin T.-K., Chang C.-C., Lu C.-H., Chang W.-N., Chen S.-D., Tan T.-Y., Huang C.-R., Chan S.H. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia 2012, 53:120-128.
13. Coppola G., Ingrosso D., Operto F.F., Signoriello G., Lattanzio F., Barone E., Matera S., Verrotti A. Role of folic acid depletion on homocysteine serum level in children and adloescents with epilepsy and different MTHFR C677T genotypes. Seizure 2012, 21:340-343.
14. Eiris J., Lojo S., Del-Rio M., Novo I., Bravo M., Pavón P., Castro-Gago M. Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy. Neurology 1995, 45:1155.
15. Elliott J.O., Jacobson M.P., Haneef Z. Cardiovascular risk factors and homocysteine in epilepsy. Epilepsy Res. 2007, 76:113-123.
16. Erdemir A., Cullu N., Yiş U., Demircioǧlu F., Kir M., Cakmakçi H., Unal N., Direk E. Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid. Brain Dev. 2009, 31:713-716.
17. Gerstner T., Woelfing C., Witsch M., Longin E., Bell N., König S. Capillary microscopy and hemorheology in children during antiepileptic monotherapy with carbamazepine and valproate. Seizure 2006, 15:606-609.
18. Gokce N., Keaney J.F., Hunter L.M., Watkins M.T., Nedeljkovic Z.S., Menzoian J.O., Vita J.A. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J. Am. Coll. Cardiol. 2003, 41:1769-1775.
19. Hamed S.A., Hamed E.A., Hamdy R., Nabeshima T. Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Res. 2007, 74:183-192.
20. Huemer M., Ausserer B., Graninger G., Hubmann M., Huemer C., Schlachter K., Tscharre A., Ulmer H., Simma B. Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation. Epilepsia 2005, 46:1677-1683.
21. Isojärvi J.I., Pakarinen A.J., Rautio A., Pelkonen O., Myllylä V.V. Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine. Epilepsia 1994, 35:1217-1220.
22. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., Selhub J., Rozen R.l. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996, 93:7-9.
23. Karabiber H., Sonmezgoz E., Ozerol E. Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid. Brain Dev. 2003, 25:113-115.
24. Kurul S., Unalp A., Yiş U. Homocysteine levels in epileptic children receiving antiepileptic drugs. J. Child Neurol. 2007, 22:1389-1392.
25. Maxwell J.D., Hunter J., Stewart D.A., Ardeman S., Williams R. Folate deficiency after anticonvulsant drugs: an effect of hepatic enzyme induction?. Br. Med. J. 1972, 1:297-299.
26. May R.B., Sunder T.R. Hematologic manifestations of long-term valproate therapy. Epilepsia 1993, 34:1098-1101.
27. McCully K. Homocysteine, vitamins, and prevention of vascular disease. Mil. Med. 2004, 169:325-329.
28. Ono H., Sakaoto A., Mizoguchi N., Sakura N. The C677T mutation in the methylenetetrahydrofolate reductase gene contributes to the hyperhomocystinemia in patients taking anticonvulsants. Brain Dev. 2002, 24:223-226.
29. Peña A.S., Wiltshire E., Mackenzie K., Gent R., Piotto L., Hirte C., Couper J. Vascular endothelial and smooth muscle function relate to body mass index and glucose in obese and non-obese children. J. Clin. Endocrinol. Metab. 2006, 91:4467-4471.
30. Pylvänen V., Pakarinen A., Knip M., Isojärvi J. Characterization of insulin secretion in valproate-treated patients with epilepsy. Epilepsia 2006, 47:1460-1464.
31. Roper N.A., Bilous R.W., Kelly W.F., Unwin N.C., Connolly V.M. Cause-specific mortality in a population with diabetes: South Tees Diabetes Mortality Study. Diabetes Care 2002, 25:43-48.
32. Sener U., Zorlu Y., Karaguzel O., Ozdamar O., Coker I., Topbas M. Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6. Seizure 2006, 15:79-85.
33. Skilton M.R., Celermajer D.S. Endothelial dysfunction and arterial abnormalities in childhood obesity. Int. J. Obes. (Lond.) 2006, 30:1041-1049.
34. Sonmez F.M., Demir E., Orem A., Yildirmis S., Orhan F., Aslan A., Topbas M. Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes. J. Child Neurol. 2006, 21:70-74.
35. Svalheim S., Luef G., Rauchenzauner M., Mørkrid L., Gjerstad L., Taubøll E. Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine. Acta Neurol. Scand. Suppl. 2010, 122:30-33.
36. Tomoum H.Y., Awadallah M.M., Fouad D.A., Ali A.H. Lipid profile, apolipoproteins A and B in children with epilepsy. J. Child Neurol. 2008, 23:1275-1281.
37. Verrotti A., Basciani F., Domizio S., Sabatino G., Morgese G., Chiarelli F. Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatr. Neurol. 1998, 19:364-367.
38. Verrotti A., Pascarella R., Trotta D., Giuva T., Morgese G., Chiarelli F. Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine. Epilepsy Res. 2000, 41:253-257.
39. Vilaseca M.A., Monrós E., Artuch R., Colomé C., Farré C., Valls C., Cardo E., Pineda M. Anti-epileptic drug treatment in children: hyperhomocysteinaemia, B-vitamins and the 677C---T mutation of the methylenetetrahydrofolate reductase gene. Eur. J. Paediatr. Neurol. 2000, 4:269-277.
40. Welch G., Loscalzo J. Homocysteine and atherothrombosis. N. Engl. J. Med. 1998, 338:1042-1050.
41. Wiltshire E., Gent R., Hirte C., Pena A., Thomas D.W., Couper J.J. Endothelial dysfunction relates to folate status in children and adolescents with type 1 diabetes. Diabetes 2002, 51:2282-2286.
42. Wiltshire E.J., Couper J.J. Improved folate status in children and adolescents during voluntary fortification of food with folate. J. Paediatr. Child Health 2004, 40:44-47.
43. Woo K.S., Chook P., Raitakari O.T., McQuillan B., Feng J.Z., Celermajer D.S. Westernization of Chinese adults and increased subclinical atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 1999, 19:2487-2493.
44. Yildiz M., Simsek G., Uzun H., Uysal S., Sahin S., Balci H. Assessment of low-density lipoprotein oxidation, paraoxonase activity, and arterial distensibility in epileptic children who were treated with anti-epileptic drugs. Cardiol. Young 2010, 20:547-554.
45. Yiş U., Doǧan M. Effects of oxcarbazepine treatment on serum lipids and carotid intima media thickness in children. Brain Dev. 2012, 34:185-188.